If approved for treatment, I hope this is fairly priced, given that the CDC predicts 40M infections in the US.<p>Just to be clear, pricing ultimately comes down to insurance companies, middlemen taking a cut, and a government mandate that can pressure the ecosystem into acting in the public interest in times of a pandemic. So please make a reasonable profit to continue developing treatments, but DON'T get greedy, especially applies to insurance companies and middlemen whose entire role is financial engineering adding next to nothing in value